CD79A and prostate cancer: Overall, in most cancers, including melanoma [63,78], lung cancer [79], bladder cancer [80], and prostate cancer [9], a high expression of IgG1 is associated with longer survival, whereas IgG4 and IgA expressions correlate with a negative outcome.